文献速递头颈外科

甲状腺嗜酸细胞癌:来自20年患者队列的结论

Oncocytic carcinoma of the thyroid: Conclusions from a 20-year patient cohort.
PubMed 文献 · Head Neck · 2024-02-23

该研究回顾性分析2000至2021年一家三级医院51例甲状腺嗜酸细胞癌(OCA)患者,平均诊断年龄60.3岁,90%以可触及肿块就诊,24%有甲状腺癌家族史;组织学显示63%有血管侵犯、35%有淋巴血管侵犯、15%有甲状腺外侵犯;77%接受放射性碘辅助治疗;作者认为OCA具有区别于其他分化型甲状腺癌的独特特征,需进一步聚焦研究以明确其侵袭性、治疗选择与预后。

要点

  • 51例OCA患者中90%以可触及肿块就诊,24%有甲状腺癌家族史。
  • 组织学上63%有血管侵犯、35%有淋巴血管侵犯、15%有甲状腺外侵犯。
  • 77%接受放射性碘辅助治疗,作者认为需进一步聚焦研究明确其侵袭性、治疗与预后。

核心结论

  • OCA具有区别于其他分化型甲状腺癌的独特特征,需进一步聚焦研究以明确其侵袭性、治疗选择与预后。

研究设计与样本

  • 回顾性分析2000至2021年一家三级医院收治的51例甲状腺嗜酸细胞癌(OCA)患者(22例男性、29例女性)。

主要发现

  • 平均诊断年龄60.3岁,90%以可触及肿块就诊,24%有甲状腺癌家族史,均无声带麻痹。
  • 超声显示多数肿瘤为实性、低回声;14例细针穿刺(FNA)中93%为Bethesda-4类病变。
  • 全部患者接受手术治疗;组织学上63%有血管侵犯、35%有淋巴血管侵犯、15%有甲状腺外侵犯。
  • 77%接受放射性碘辅助治疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Oncocytic carcinoma (OCA) was recently reclassified as a distinct differentiated thyroid carcinoma (DTC). Given its rarity, OCA studies are limited. This study describes the characteristics of OCA in a 20-year cohort. METHODS: Retrospective analysis of patients with OCA at a single tertiary care hospital from 2000 to 2021. RESULTS: Fifty-one OCA patients (22M:29F) were identified. The mean age at diagnosis was 60.3 years; 90% presented as palpable mass; 24% had a family history of thyroid cancer. None had vocal fold paresis. On ultrasound, most tumors were solid and hypoechoic. FNA (n = 14) showed Bethesda-4 lesions in 93%. All were treated surgically. Histologically, 63% demonstrated angioinvasion, 35% had lymphovascular invasion, and 15% had extrathyroidal extension. Radioactive iodine was used as adjunct therapy in 77%. CONCLUSION: OCA has distinct features that distinguish it from other DTCs, and additional focused studies will help clarify the aggressive nature, treatment options, and prognosis of the disease.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Gruszczynski NR, Hasan SS, Brennan AG, et al. Oncocytic carcinoma of the thyroid: Conclusions from a 20-year patient cohort. Head Neck. 2024. PMID: 38390640. doi:10.1002/hed.27700

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。